Cassava Sciences, Inc.
(NASDAQ : SAVA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. 0.12%283.741.5%$847.25m
GILDGilead Sciences, Inc. 0.98%86.261.0%$795.01m
MRNAModerna, Inc. -0.23%176.400.0%$769.19m
VRTXVertex Pharmaceuticals, Inc. -1.01%312.981.9%$482.01m
REGNRegeneron Pharmaceuticals, Inc. 0.12%736.232.6%$473.28m
BIIBBiogen, Inc. 0.56%305.151.8%$355.07m
ILMNIllumina, Inc. -1.39%218.993.2%$270.73m
SNSSSunesis Pharmaceuticals, Inc. 5.70%2.780.7%$194.33m
BMRNBioMarin Pharmaceutical, Inc. -0.89%96.924.2%$161.47m
BNTXBioNTech SE -0.88%154.850.0%$152.12m
MRTXMirati Therapeutics, Inc. 2.89%98.621.6%$132.21m
TECHBio-Techne Corp. 0.79%338.974.5%$123.89m
AXSMAxsome Therapeutics, Inc. 1.07%56.821.6%$80.71m
NVAXNovavax, Inc. -2.88%16.5475.3%$70.44m
HALOHalozyme Therapeutics, Inc. 0.59%54.6718.4%$64.50m

Company Profile

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.